Notice of NHGRI Participation in PAR-20-041, Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed)

Notice Number: NOT-HG-20-027

Key Dates
Release Date: March 13, 2020

Related Announcements

PAR-20-039

PAR-20-040

Issued by
National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Human Genome Research Institute (NHGRI) is participating inPAR-20-041 Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed).

The following sections have been updated to reflect the participation of NHGRI in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute of General Medical Sciences (NIGMS))
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Human Genome Research Institute (NHGRI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.859; 93.866; 93.853; 93.855; 93.847; 93.121; 93.173, 93.113, 93.233, 93.837, 93.838, 93.839, 93.840;93.279; 93.172.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Luis A. Cubano, Ph.D.
National Human Genome Research Institute
Phone: 301-480-3435
Email: luis.cubano@nih.gov

Financial/Grants Management Contact(s)

Deanna Ingersoll
Phone: 301-435-7858
Email: Deanna.ingersoll@nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Luis A. Cubano, Ph.D.
National Human Genome Research Institute
Phone: 301-480-3435
Email: luis.cubano@nih.gov